Cargando…
P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell lines
BACKGROUND: Mantle cell lymphoma (MCL) is a well-defined aggressive lymphoid neoplasm characterized by proliferation of mature B-lymphocytes that have a remarkable tendency to disseminate. This tumor is considered as one of the most aggressive lymphoid neoplasms with poor responses to conventional c...
Autores principales: | Shirsath, Nitesh P, Manohar, Sonal M, Joshi, Kalpana S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558400/ https://www.ncbi.nlm.nih.gov/pubmed/23075291 http://dx.doi.org/10.1186/1476-4598-11-77 |
Ejemplares similares
-
Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells
por: Rathos, Maggie J, et al.
Publicado: (2013) -
Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers
por: Rathos, Maggie J, et al.
Publicado: (2012) -
Molecular mechanisms of anti-tumor properties of P276-00 in head and neck squamous cell carcinoma
por: Mishra, Prabha B, et al.
Publicado: (2013) -
Targeting cyclin D1 for mantle cell lymphoma
por: Chen, Jingtao
Publicado: (2015) -
Inhibition of cyclin‐dependent kinase 9 synergistically enhances venetoclax activity in mantle cell lymphoma
por: Zhao, Xiaoxian, et al.
Publicado: (2020)